The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK

BACKGROUND: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid [ICS] plus long-acting β(2)-agonist bronchodilator [LABA] plus long-acting muscarinic antagonist) differ from Global initiative for chronic Obstructive Lung Disease [GOLD] and National Institute for H...

Descripción completa

Detalles Bibliográficos
Autores principales: Brusselle, Guy, Price, David, Gruffydd-Jones, Kevin, Miravitlles, Marc, Keininger, Dorothy L, Stewart, Rebecca, Baldwin, Michael, Jones, Rupert C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621207/
https://www.ncbi.nlm.nih.gov/pubmed/26527869
http://dx.doi.org/10.2147/COPD.S91694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621207/
https://www.ncbi.nlm.nih.gov/pubmed/26527869
http://dx.doi.org/10.2147/COPD.S91694

Ejemplares similares